Company intelligence / Profile preview
BIORCHESTRA
Daejeon, South Koreabiorchestra.com ↗
- Ownership
- Private
- Employees
- ~20
- Development stage
- Other
01
Overview
BIORCHESTRA develops proprietary RNA-based therapeutics targeting neurodegenerative and rare CNS diseases. Its lead program aims at Alzheimer’s disease by modulating specific microRNAs upstream of pathological proteins like Aβ and tau. The company has demonstrated preclinical efficacy with its antisense oligonucleotide approach delivered via a novel intravenous system capable of crossing the blood-brain barrier. Clinical entry was anticipated for their Alzheimer’s candidate in early/mid–2024.
- Therapeutic areas
- Rare DiseasesNeurology
- Modalities
- RNA-based therapeutics (including antisense oligonucleotides, siRNA, microRNA modulators)
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
Dayli PartnersCKD Venture CapitalLSK Investmentopen innovation collaborations with global pharmaceutical companies on drug delivery systems.
Beyond the preview
Go deeper on BIORCHESTRA.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BIORCHESTRA.